News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Sanofi US
NEWS
JOBS
IN THE PRESS
NEWS
BioMidwest
Sanofi-Aventis (France) Ambien May Prompt Sleep-Eating
March 15, 2006
·
1 min read
BioCapital
World Health Organization Calls For Halt On Malaria Treatment
January 19, 2006
·
1 min read
The Day In Review: Biotech Marks 5-Year Anniversary Of Nasdaq Bubble Quietly
October 19, 2005
·
1 min read
Pharm Country
Plavix Saves Lives After Big Heart Attacks
October 19, 2005
·
1 min read
Sanofi-Aventis Experimental Diet Pill Keeping Pounds Off; Some Snags
October 19, 2005
·
1 min read
Ten Drugs To Watch
October 19, 2005
·
3 min read
Deals
Merger Mania Besets Japanese Pharmaceuticals
October 19, 2005
·
1 min read
Policy
Eight Pharmaceutical Leaders Initiate New Company To Manage And Promote Digital Identity Assurance Standard Across The Biopharmaceutical Industry
October 19, 2005
·
1 min read
Bated Breath For Inhaled Insulin
October 19, 2005
·
1 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Libertas Bio, a Formation Bio subsidiary, License of Gusacitinib, a Dual JAK/SYK Inhibitor, to Sanofi
June 23, 2025
·
2 min read
Press Releases
Press Release: Itepekimab met the primary endpoint in one of two COPD phase 3 studies
May 30, 2025
·
16 min read
Press Releases
Sanofi opens new, $130 million NJ offices in Morristown, showcasing innovative, modern design and strengthening US presence
May 23, 2025
·
5 min read
Press Releases
Nurix Licenses a Drug Discovery Program to Sanofi Targeting a Novel Transcription Factor for Autoimmune Diseases
April 2, 2025
·
7 min read
Press Releases
Sanofi adopts FDA-selected flu strains to ensure readiness for the 2025-26 flu season
March 17, 2025
·
7 min read
Press Releases
Indapta Therapeutics Announces Clinical Study Collaboration With Sanofi on Multiple Myeloma Program
December 6, 2024
·
2 min read
Press Releases
Sanofi commits $18 million to Howard University College of Medicine, Meharry Medical College, and Morehouse School of Medicine to increase diversity in clinical studies
October 16, 2024
·
5 min read
Press Releases
Fluzone® High-Dose Quadrivalent vaccine remains preferentially recommended to protect adults 65 years of age and older against influenza
July 26, 2024
·
4 min read
Press Releases
Sanofi ships U.S. influenza vaccines for the 2024/25 season
July 11, 2024
·
7 min read
Press Releases
Cosette Pharmaceuticals Acquires Ambien® and Ambien CR® (Zolpidem Tartrate) Tabs from Sanofi US in the US Market
July 10, 2024
·
2 min read